iBio, Inc.

NASDAQ:IBIO

Biotechnology

Healthcare
$0.80 +0.00%

+$0.00 today

Market cap
$56.44M
Beta
1.29
P/E (TTM)
-3.6
EPS (TTM)
-$0.32
52W Low $0.78High $3.82

Volume 0.43M

Average 0.81M

Income Statement

Follow revenue through to earnings.

Revenue

$100,000.00

FY 2026 · Annual

-75.0% YoY

Operating Income

-$35.14M

FY 2026 · Annual

Net Income

-$33.04M

FY 2026 · Annual

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue1.88M0225K400K100K
Cost of Revenue3.79M0000
Gross Profit(1.91M)0225K400K100K
Gross Margin-101.2%—100.0%100.0%100.0%
Research & Development9.83M10.33M5.19M8.31M19.64M
Selling, General & Admin17.96M18.45M11.67M10.69M10.6M
Operating Expenses27.79M29.34M16.86M19M35.24M
Depreciation & Amortization3.79M1.38M1.25M1.13M646K
EBITDA(25.72M)(27.85M)(14.02M)(17.04M)(32.35M)
EBITDA Margin-1365.3%—-6231.6%-4259.8%-32345.0%
Operating Income(29.7M)(29.34M)(16.63M)(18.6M)(35.14M)
Operating Margin-1576.3%—-7392.9%-4650.5%-35141.0%
Interest Income177K213K363K437K2.15M
Interest Expense1.41M83K172K212K53K
Other Income / Expenses184K32K1.19M225K2.1M
Income Before Tax(29.51M)(29.31M)(15.44M)(18.38M)(33.04M)
Pre-Tax Margin-1566.5%—-6863.6%-4594.3%-33044.0%
Income Tax Expense00000
Net Income(50.39M)(65.01M)(24.91M)(18.38M)(33.04M)
Net Margin-2674.7%—-11069.8%-4594.3%-33044.0%
EPS (Basic)(2,889.06)(106.18)(6.50)(1.75)(0.32)
EPS (Diluted)(2,889.06)(106.18)(6.50)(1.75)(0.32)
Weighted Avg Shares17.44K612.25K3.83M10.5M104.06M
Weighted Avg Shares (Diluted)17.44K612.25K3.83M10.5M104.06M

IBIO Earnings Waterfall · TTM

NASDAQ:IBIO · Revenue to Net Income

Key Ratios

EPS$-0.33
Gross Margin-47.3%
Net Margin-1430.0%
P/E Ratio-5.5
P/S Ratio109.6

Analysis

$100.0K of revenue converted into -$33.0M of net income for the selected period. Gross margin is -47.3% and net margin is -1430.0%, showing how much revenue survives after costs and taxes. EPS is $-0.33, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportOct 19, 2026
4Statement of changes in beneficial ownershipOct 15, 2026
4Statement of changes in beneficial ownershipOct 15, 2026

How much revenue does IBIO generate?

iBio, Inc. (IBIO) reported $100,000.00 of revenue in fiscal 2026.

Is IBIO profitable?

iBio, Inc. (IBIO) reported -$33.04M of net income, with a net margin of -33044.0%.